4-[(8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide

InChIKey	`XQVVPGYIWAGRNI-UHFFFAOYSA-N`
Compound Name	4-[(8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl)amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
Canonical SMILES	`CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	19
Pfam Stratification	Cross-Family
Avg pChEMBL	6.61
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
Q9H4B4	PLK3	Homo sapiens	Human	PF00069 PF00659	8.3	Ki	ChEMBL
O60885	BRD4	Homo sapiens	Human	PF17035 PF17105 PF00439	7.6	IC50	ChEMBL
O43293	DAPK3	Homo sapiens	Human	PF00069	7.1	Ki	ChEMBL
O94806	PRKD3	Homo sapiens	Human	PF00130 PF00169 PF00069 PF25525	6.9	Ki	ChEMBL
Q13557	CAMK2D	Homo sapiens	Human	PF08332 PF00069	6.8	Ki	ChEMBL
Q13555	CAMK2G	Homo sapiens	Human	PF08332 PF00069	6.7	Ki	ChEMBL
P00533	EGFR	Homo sapiens	Human	PF00757 PF14843 PF07714 PF01030 PF21314	6.6	Ki	ChEMBL
Q14680	MELK	Homo sapiens	Human	PF02149 PF00069 PF21594	6.6	Ki	ChEMBL
Q9UM73	ALK	Homo sapiens	Human	PF12810 PF00629 PF07714	6.6	Ki	ChEMBL
Q9BZL6	PRKD2	Homo sapiens	Human	PF00130 PF00169 PF00069 PF25525	6.5	Ki	ChEMBL
P07332	FES	Homo sapiens	Human	PF00611 PF07714 PF00017	6.4	Ki	ChEMBL
P49760	CLK2	Homo sapiens	Human	PF00069	6.3	Ki	ChEMBL
Q05397	PTK2	Homo sapiens	Human	PF21477 PF00373 PF18038 PF03623 PF07714	6.3	Ki	ChEMBL
O95819	MAP4K4	Homo sapiens	Human	PF00780 PF00069	6.2	Ki	ChEMBL
P15735	PHKG2	Homo sapiens	Human	PF00069	6.2	Ki	ChEMBL
Q14289	PTK2B	Homo sapiens	Human	PF21477 PF00373 PF18038 PF03623 PF07714	6.2	Ki	ChEMBL
Q9H2G2	SLK	Homo sapiens	Human	PF00069 PF12474	6.1	Ki	ChEMBL
Q9Y6M4	CSNK1G3	Homo sapiens	Human	PF12605 PF00069	6.1	Ki	ChEMBL
P51957	NEK4	Homo sapiens	Human	PF00069	6.0	Ki	ChEMBL